clinvestКачественная клиническая практикаKachestvennaya Klinicheskaya Praktika = Good Clinical Practice2588-05192618-8473ООО «Издательство ОКИ10.37489/2588-0519-2020-S4-32-34clinvest-522Research ArticleАКТУАЛЬНЫЕ ОБЗОРЫACTUAL REVIEWВозможно ли применение ингаляций раствора гиалуронидазы в лечении острого респираторного дистресс-синдрома у пациентов с COVID-19?Can inhalations of hyaluronidase be used in acute respiratory distress-syndrome in patients with COVID-19?https://orcid.org/0000-0002-6753-8572КиселёвЮ. Ю.KiselevYu. Yu.

Киселёв Юрий Юрьевич – PhD, доцент факультета наук о здоровье OsloMet

Осло

Kiselev Yuri Yu. – PhD, Associate Professor at the Faculty of Health Sciences OsloMet

Oslo

https://orcid.org/0000-0002-9307-4994МирзаевК. Б.MirzaevK. B.

Мирзаев Карин Бадавиевич – к. м. н., доцент кафедры клинической фармакологии и терапии. SPIN-код: 8308-7599

Москва

Mirzaev Karin B. – Candidate of Medical Sciences, Associate Professor of the Department of Clinical Pharmacology and Therapy. SPIN code: 8308-7599

Moscow

https://orcid.org/0000-0002-4496-3680СычёвД. А.SychevD. A.

Сычёв Дмитрий Алексеевич – д. м. н., профессор, член-корр. РАН, ректор, зав. кафедрой клинической фармакологии и терапии. SPIN-код: 4525-7556

Москва

Sychev Dmitry A. – Doctor of Medical Sciences, Professor, Corresponding Member RAS, Rector, Head Department of Clinical Pharmacology and Therapy. SPIN code: 4525-7556

Moscow

dmitriy.alex.sychev@gmail.comУниверситет Осло МетрополитенНорвегияOslo Metropolitan UniversityNorwayФГБОУ ДПО «Российская медицинская академия непрерывного профессионального образования» Минздрава РоссииРоссияRussian Medical Academy of Continuing Professional Education of the Ministry of Health of RussiaRussian Federation20202710202004SФармаCOVID3234Copyright © Киселёв Ю.Ю., Мирзаев К.Б., Сычёв Д.А., 20202020Киселёв Ю.Ю., Мирзаев К.Б., Сычёв Д.А.Kiselev Y.Y., Mirzaev K.B., Sychev D.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.clinvest.ru/jour/article/view/522

Гиалуронидаза в настоящее время не включена в российские или зарубежные рекомендации по лечению ОРДС при COVID-19 и не имеет убедительных доказательств клинической эффективности в лечении этого состояния. Применение гиалуронидазы возможно исключительно в рамках клинических исследований.

Hyaluronidase is currently not included into Russian or foreign guidelines on the treatment of acute respiratory distress-syndrome in patients with COVID-19, and such treatment is not supported by evidence of clinical effectiveness. Hyaluronidase can only be used for COVID-19 within clinical trials.

коронавирусгиалуронидазаострый респираторный дистресс-синдромCOVID-19coronavirushyaluronidasecute respiratory distress-syndromeCOVID-19ReferencesГосударственный реестр лекарственных средств. ЛСР-007075_08Государственный реестр лекарственных средств. ЛСР-007075_08https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021716lbl.pdfhttps://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021716lbl.pdfhttps://www.medicines.org.uk/emc/product/1505/smpc#INDICATIONShttps://www.medicines.org.uk/emc/product/1505/smpc#INDICATIONSOh BL, Jung C, Park KH, Hong YJ, Woo SJ. Therapeutic Intra-arterial Hyaluronidase Infusion for Ophthalmic Artery Occlusion Following Cosmetic Facial Filler (Hyaluronic Acid) Injection. Neuro-Ophthalmology. 2014;38(1):39—43. Published 2014 Jan 28. DOI: 10.3109/01658107.2013.830134Oh BL, Jung C, Park KH, Hong YJ, Woo SJ. Therapeutic Intra-arterial Hyaluronidase Infusion for Ophthalmic Artery Occlusion Following Cosmetic Facial Filler (Hyaluronic Acid) Injection. Neuro-Ophthalmology. 2014;38(1):39—43. Published 2014 Jan 28. DOI: 10.3109/01658107.2013.830134Juul SE, Kinsella MG, Truog WE, Gibson RL, Redding GJ. Lung hyaluronan decreases during group B streptococcal pneumonia in neonatal piglets. Am J Respir Crit Care Med. 1996;153(5):1567—1570. DOI: 10.1164/ajrccm.153.5.8630603Juul SE, Kinsella MG, Truog WE, Gibson RL, Redding GJ. Lung hyaluronan decreases during group B streptococcal pneumonia in neonatal piglets. Am J Respir Crit Care Med. 1996;153(5):1567—1570. DOI: 10.1164/ajrccm.153.5.8630603Uchakina ON, Castillejo CM, Bridges CC, McKallip RJ. The role of hyaluronic acid in SEB-induced acute lung inflammation. Clin Immunol. 2013;146(1):56—69. DOI: 10.1016/j.clim.2012.11.002Uchakina ON, Castillejo CM, Bridges CC, McKallip RJ. The role of hyaluronic acid in SEB-induced acute lung inflammation. Clin Immunol. 2013;146(1):56—69. DOI: 10.1016/j.clim.2012.11.002www.clinicaltrials.govwww.clinicaltrials.govhttps://grls.rosminzdrav.ru/CiPermitionReg.aspxhttps://grls.rosminzdrav.ru/CiPermitionReg.aspxShi Y, Wang Y, Shao C et al. COVID-19 infection: the perspectives on immune responses. Cell Death Differ. 2020 May;27(5):1451-1454. DOI: 10.1038/s41418-020-0530-3Shi Y, Wang Y, Shao C et al. COVID-19 infection: the perspectives on immune responses. Cell Death Differ. 2020 May;27(5):1451-1454. DOI: 10.1038/s41418-020-0530-3Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020 Apr;8(4):420-422. DOI: 10.1016/S22132600(20)30076-XXu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020 Apr;8(4):420-422. DOI: 10.1016/S22132600(20)30076-XHallgren R, Samuelsson T, Laurent TC, Modig J. Accumulation of hyaluronan (hyaluronic acid) in the lung in adult respiratory distress syndrome. Am Rev Respir Dis. 1989 Mar;139(3):682-7. DOI: 10.1164/ajrccm/139.3.682Hallgren R, Samuelsson T, Laurent TC, Modig J. Accumulation of hyaluronan (hyaluronic acid) in the lung in adult respiratory distress syndrome. Am Rev Respir Dis. 1989 Mar;139(3):682-7. DOI: 10.1164/ajrccm/139.3.682Bell TJ, Brand OJ, Morgan DJ et al. Defective lung function following influenza virus is due to prolonged, reversible hyaluronan synthesis. Matrix Biol. 2019 Jul;80:14-28. DOI: 10.1016/j.matbio.2018.06.006Bell TJ, Brand OJ, Morgan DJ et al. Defective lung function following influenza virus is due to prolonged, reversible hyaluronan synthesis. Matrix Biol. 2019 Jul;80:14-28. DOI: 10.1016/j.matbio.2018.06.006https://www.ficm.ac.uk/sites/default/files/ficm_ics_ards_guideline_-_july_2018.pdfhttps://www.ficm.ac.uk/sites/default/files/ficm_ics_ards_guideline_-_july_2018.pdfGriffiths MJD, McAuley DF, Perkins GD et al. Guidelines on the management of acute respiratory distress syndrome. BMJ Open Respir Res. 2019 May 24;6(1):e000420. DOI: 10.1136/bmjresp-2019-000420Griffiths MJD, McAuley DF, Perkins GD et al. Guidelines on the management of acute respiratory distress syndrome. BMJ Open Respir Res. 2019 May 24;6(1):e000420. DOI: 10.1136/bmjresp-2019-000420Клинические рекомендации «Диагностика и интенсивная терапия острого респираторного дистресс-синдрома». http://far.org.ru/recomendationClinical guidelines «Diagnosis and intensive therapy of acute respiratory distress syndrome». (In Russ). http://far.org.ru/recomendationhttps://static-1.rosminzdrav.ru/system/attachments/attaches/000/050/122/original/28042020_%D0%9CR_COVID-19_v6.pdfhttps://static-1.rosminzdrav.ru/system/attachments/attaches/000/050/122/original/28042020_%D0%9CR_COVID-19_v6.pdf

The authors declare that there are no conflicts of interest present.